tsh biopharmoration Ltd (8432)

Currency in TWD
48.00
-0.30(-0.62%)
Closed·

8432 Financial Summary

Key Ratios

P/E Ratio16.11
Price/Book1.38
Debt / Equity1.28%
Return on Equity9.75%
Dividend Yield4.42%
EBITDA185.11M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of TWD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.99%
Dividend Yield
4.42%
Industry Median 2.51%
Annualised payout
2.12
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 12, 2025
EPS / Forecast
0.79 / --
Revenue / Forecast
287.12M / --
EPS Revisions
Last 90 days

FAQ

What were tsh biopharmoration's earnings for the latest quarter?

The tsh biopharmoration EPS (TTM) is 2.99. tsh biopharmoration reported sales of 269.30, net income of 26.20, and EPS of 0.79 for the latest quarter.

What was tsh biopharmoration's net income for the latest quarter?

tsh biopharmoration's net income for the latest quarter was 26.20.

How did tsh biopharmoration's performance compare year-over-year in the latest quarter?

The company's revenue moved from 287.12 in the previous quarter to 269.30 in the latest quarter, and net income moved from 30.41 to 26.20 compared to the previous quarter.

What is tsh biopharmoration's net profit margin on a TTM basis?

tsh biopharmoration's trailing twelve months (TTM) net profit margin is 10.14%.

How does tsh biopharmoration's debt to equity ratio compare to industry standards?

tsh biopharmoration's total debt-to-equity ratio is 1.28%.

What is tsh biopharmoration's return on investment on a TTM basis?

tsh biopharmoration's trailing twelve months (TTM) return on investment (ROI) is 9.75%.

Did tsh biopharmoration gain or lose cash last quarter?

In the latest quarter, tsh biopharmoration's net change in cash was 36.55 million.

What were tsh biopharmoration's total assets and liabilities in the latest quarter?

As of the latest quarter, tsh biopharmoration reported total assets of 1,851.95 million and total liabilities of 264.14 million.

How has tsh biopharmoration's total revenue grown this year?

tsh biopharmoration's total revenue was 287.12 in the previous quarter and 269.30 in the latest quarter.

What is tsh biopharmoration's gross margin on a TTM basis?

tsh biopharmoration's trailing twelve months (TTM) gross margin is 51.22%.

What was tsh biopharmoration's revenue per share for the latest quarter?

tsh biopharmoration's revenue per share for the latest quarter was 22.73.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.